跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vial
Approved
STANDARD
ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vial
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e5b4af67061929c7
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e5b4af67061929c7
Product Name
ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vial
Artg Id
278727
Artg Name
ADYNOVATE rurioctocog alfa pegol (rch) 500 IU powder for injection vial with diluent vial
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2017-03-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/81f9020fcd6e70fd03c8a0beff997807.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f3e6f1bbbfb379db46c71bd792a90ca7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e5b4af67061929c7
Type
Standard
Back to TGA Approvals